Rationale For Extracorporeal Support

Pathophysiology Of Liver Failure

  • Necrosed hepatocytes release toxins and inflammatory mediators.
  • Initiates cascade leading to multiorgan failure.
  • Elicits vicious cycle of autointoxication.

Purpose Of Liver Assist Devices

  • Interrupts autointoxication cycle via toxin removal.
  • Provides opportunity for native liver regeneration.
  • Evaluated as temporary bridge to liver transplantation or spontaneous regeneration.

Ideal Extracorporeal Liver Support System

Required Functional Capabilities

  • Requires performance of complex synthetic functions.
  • Demands detoxifying capabilities.
  • Necessitates biotransformatory functions mimicking hepatocytes and Kupffer cells.

Classification Of Liver Support Devices

  • Broadly classified into cell-free cleansing devices and bioartificial liver support systems.

Comparative Analysis Of Liver Support Systems

System FeatureCell-Free Cleansing DevicesBioartificial Liver Support Systems
System TypeNon-biologic systemBiologic liver support system
Primary MechanismLiver dialysisPerfusion of blood through cellular cartridge
Core ComponentsAlbumin-containing dialysateHuman liver cells, liver cell lines, porcine hepatocytes
Liver Functions ProvidedDetoxifying function onlySynthetic, detoxifying, and biotransformatory functions
Theoretical AdvantageBasic toxin filtrationMimics complex hepatocyte and Kupffer cell properties

Data compiled from.

Clinical Outcomes And Efficacy

Biochemical And Neurological Impact

  • Removes circulating toxins effectively.
  • Decreases serum ammonia, bilirubin, and inflammatory cytokines.
  • Improves serum biochemical abnormalities.
  • Improves neurologic function in select cases.

Mortality And Survival

  • Demonstrates no significant effect on overall mortality.
  • Yields little evidence of improved survival rates.
  • Remains elusive for successful use as reliable bridge therapy.

Limitations In Pediatric Practice

Clinical Constraints

  • Remains strictly experimental.
  • Not recommended outside formal research settings.
  • High cost prohibits widespread clinical application.

Pediatric-Specific Challenges

  • Suffers from nonavailability of small filters appropriate for children.
  • Lacks robust safety data in pediatric populations.
  • Few children have received this specific treatment modality.